44.1 2020 Year in Review: Simplifying NASH Diagnostics Saves Money, improves satisfaction
Send us Fan Mail Ian Rowe discusses how streamlined use of ELF, FIB-4 and FibroScan improves cost effectiveness and patient satisfaction associated with NASH screening. Ian Rowe comments on data from...
1 Tammi 202122min
2020 Year-End NASH Review 2: Patient Treatment and Perspectives
Send us Fan Mail Guests Ian Rowe, Joern Schattenberg and Wayne Eskridge join the Surfers to discuss key lessons learned in 2020 about Patient Treatment and Perspectives. Ian Rowe, Joern Schattenberg ...
30 Joulu 20201h 26min
43.4 2020 Year in Review: The Law of Unintended Consequences Blesses NASH Drug Development
Send us Fan Mail Roger Green discusses why despite widespread concerns, FDA's Complete Response Letter to Intercept did not cripple progress in NASH drug development. Observers feared that after Inte...
25 Joulu 202016min
43.3 2020 Year in Review: Progress in developing clinical endpoints necessary to support drug approvals
Send us Fan Mail Stephen Harrison summarizes a year of progress in improving the tests and analyses used to derive clinical endpoints necessary to initial drug approvals. Despite reports earlier in t...
25 Joulu 202013min
43.2 2020 Year In Review: Emergence of Non-Invasive Tests and Testing Strategies in fatty Liver Disease
Send us Fan Mail Mazen Noureddin describes a year in which biopsy's shortcomings are revealed at the same time as non-invasive testing becomes better and produces more robust data. Mazen Noureddin di...
25 Joulu 202023min
43.1 2020 Year in Review: Advances in Fatty Liver Disease Drugs and Diagnostics
Send us Fan Mail Vlad Ratziu discusses a "boiling hot" field of emerging NASH drugs and "particularly rich" data coming from no-invasive diagnostic testing. Despite elafibranor failing, obeticholic a...
25 Joulu 202023min
2020 Year-End NASH Review 1: Drugs and Diagnostics - Ep 43
Send us Fan Mail The Surfers and guests Vlad Ratziu and Mazen Noureddin discuss key lessons learned in 2020 about Drugs and Diagnostics. Vlad Ratziu and Mazen Noureddin join the Surfers to explore so...
24 Joulu 20201h 17min
Policy 2: Credibility, Convergence and the 2021 Global Liver Institute Action Plan - Ep 42
Send us Fan Mail Donna Cryer and Global Liver Institute Director of Policy Andrew Scott return to discuss their 2021 US NASH Action Plan, garnering support for the new COVID-19 vaccines and the import...
17 Joulu 202048min
